Craig Hofmeister, MD, MPH | Authors

December 24, 2021

Experts in the multiple myeloma field discuss which front-line therapy is best for patients who are treatment ineligible.

October 21, 2021

After reviewing implications of the MAIA study in multiple myeloma, experts consider unmet needs and future directions in care.

October 21, 2021

Panelists discuss the case of a 77-year-old man with newly diagnosed multiple myeloma who wishes to discontinue therapy after achieving a very good partial response.

October 14, 2021

Experts review the case of a 75-year-old woman with newly diagnosed multiple myeloma and discuss treatment selection, continuation, reduction, and duration.

October 14, 2021

In-depth considerations for available frontline therapy regimens for patients with transplant-ineligible multiple myeloma.

October 07, 2021

A panel of experts reflects on appropriate actions to take after a patient achieves adequate response to therapy for transplant-ineligible multiple myeloma.

October 07, 2021

Shared insight on how best to assess a patient’s response to therapy for transplant-ineligible multiple myeloma.

September 30, 2021

Panelists elucidate how to determine transplant ineligibility and the goals of therapy while managing a patient with multiple myeloma.

September 30, 2021

Shared insight on the difficulties of transplant-ineligible newly diagnosed multiple myeloma and how to optimally approach treatment.